Feminizing Hormone Therapy and Subclinical Indicators of CVD Risk in Transgender Women With HIV

被引：0
|
作者：
Nogueira, Nicholas Fonseca
Salazar, Ana S.
Ma Ruixuan
Aguilar, Natalie
Gonzalez, Alex
Porras, Valeria
Parker, Meela
Mantero, Alejandro
Hurwitz, Barry E.
Alcaide, Maria L.
Martinez, Claudia
机构：
来源：
CIRCULATION | 2021年 / 144卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A14353
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [41] Neighborhoods, Stress, and CVD Risk Among Women Living with HIV
    Bannon, Jacqueline
    Weber, Kathleen
    Brawner, Bridgette
    Hanlon, Alexandra
    Teitelman, Anne
    NURSING RESEARCH, 2019, 68 (02) : E138 - E138
  • [42] Gender-affirming hormone therapy in transgender women and risk of prostate cancer: pathophysiological mechanisms and clinical implications
    Bologna, Eugenio
    Licari, Leslie Claire
    Franco, Antonio
    Ditonno, Francesco
    Leonardo, Costantino
    De Nunzio, Cosimo
    Autorino, Riccardo
    Manfredi, Celeste
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024, 28 (1) : 91 - 93
  • [43] HIV Risk Perception, HIV Knowledge, and Sexual Risk Behaviors among Transgender Women in South Florida
    De Santis, Joseph P.
    Hauglum, Shayne D.
    Deleon, Diego A.
    Provencio-Vasquez, Elias
    Rodriguez, Allan E.
    PUBLIC HEALTH NURSING, 2017, 34 (03) : 210 - 218
  • [44] Managing the risk of venous thromboembolism in transgender adults undergoing hormone therapy
    Goldstein, Zil
    Khan, Musaub
    Reisman, Tamar
    Safer, Joshua D.
    JOURNAL OF BLOOD MEDICINE, 2019, 10 : 209 - 216
  • [45] Incident Diabetes Risk Is Not Increased in Transgender Individuals Using Hormone Therapy
    van Velzen, Daan
    Wiepjes, Chantal
    Nota, Nienke
    van Raalte, Daniel
    de Mutsert, Renee
    Simsek, Suat
    den Heijer, Martin
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (05): : E2000 - E2007
  • [46] ASSESSING THE EFFECTS OF HORMONE THERAPY ON ATHEROSCLEROTIC CARDIOVASCULAR RISK IN TRANSGENDER ADOLESCENTS
    Nguyen, Cassidy M.
    Lanier, Nicola E.
    Mihalopoulos, Nicole L.
    JOURNAL OF ADOLESCENT HEALTH, 2022, 70 (04) : S28 - S29
  • [47] Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
    Aranda, Gloria
    Halperin, Irene
    Gomez-Gil, Esther
    Hanzu, Felicia A.
    Segui, Nuria
    Guillamon, Antonio
    Mora, Mireia
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [48] HIV RISK BEHAVIORS AMONG MAHUWAHINE (NATIVE HAWAIIAN TRANSGENDER WOMEN)
    Ellingson, Lyndall
    Odo, Carol
    AIDS EDUCATION AND PREVENTION, 2008, 20 (06) : 558 - 570
  • [49] Arterial and venous thrombosis after long-term and excessive feminizing gender-affirming hormone therapy in a transgender woman
    Kambayashi, Makoto
    Omote, Kazunori
    Sato, Takuma
    Anzai, Toshihisa
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2023, 24 (12) : E301 - E301
  • [50] TRANSGENDER WOMEN IN LEBANON: A QUALITATIVE STUDY TO UNDERSTAND HIV/STIS RISK
    Maatouk, Ismael
    Jaspal, Rusi
    SEXUALLY TRANSMITTED INFECTIONS, 2019, 95 : A360 - A360
12345